维普期刊资源整合服务平台（V6.5）

64篇 您的检索式：作者名="GRESSNER OA"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	BMP-7 as antagonist of organ fibrosis显示文摘	Weiskirchen R Meurer SK Gressner OA	2009	Front Biosci(Landmark Ed)2009，14，：	1
2	Differentialeffects of TGF - β on connective tissue growth factor ( CTGF /CCN2) expression in hepatic stellate cells and hepatocytes显示文摘	GRESSNER OA LAHME B DEMIRCI I	2007	JHepatol2007，47，5：	1
3	BMP-7 as antagonist of organ fibrosis显示文摘	Yeiskirchen R Meurer SK Gressner OA	2009	Front Biosci2009，14，：	1
4	Biom arkers of liver fibrosis:clinical translation of m olecular pathogenesis or based onliver-dependentm alfunction tests显示文摘	Gressner OA W eiskirchen R Gressner AM	2007	Clin Chim Acta2007，381，2：	1
5	Biomarkers of liver fibrosis: clinical translation o{ molecular pathogenesis or based on liver-dependent malfunction tests 显示文摘	Gressner OA Weiskirchen R Gressner AM	2007	Clin Chim Acta2007，381，2：	1
6	Inverse association between serum concentrations of aetin-free vitamin D-binding protein and the histopathological extent of fibrogenie liver disease or hepatocellular carcinoma 显示文摘	Gressner OA Gao C Siluschek M	2009	Eur J Gastroenterol Hepatol2009，21，：	1
7	High C5a levels are as?sociated with increased mortality in sepsis patients-no enhancing effect by actin-free Gc-globulin显示文摘	Gressner OA Koch A Sanson E	2008	Clin Biochem2008，41，12：	1
8	Differential effects of TGF-beta on connective tissue growth factor (CTGF/CCN2) expression in hepatic stellate cells and hepatoeytes 显示文摘	Gressner OA Lahme B Demirei I	2007	J Hepatol2007，47，5：	1
9	Intracrine signalling ofactivin A in hepatocytes upregulates connective tissue growthfactor(CTGF/CCN2)expression显示文摘	Gressner OA Lahme B Siluschek M	2008	Liver Int2008，28，9：	1
10	Less Srmd2 is good for you! A scientific update on cof- fee' s liver benefits显示文摘	Gressner OA	2009	Hepatology2009，，50：	1
11	BMP-7 as antagonist of organ fibrosis显示文摘	Weiskirchen R Meurer SK Gressner OA	2009	Front biosci2009，14，：	1
12	Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options显示文摘	Greasner OA Weiskirchen R Gressner AM		0，，：	1
13	Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases显示文摘	Gressner OA Gressner AM	2008	Liver Int2008，28，8：	1
14	Connective tissue growth facto,r: a fibrogenic master switch in fibrotic liver diseases显示文摘	Gressner OA Gressner AM	2008	Liver lnt2008，28，8：	1
15	Evaluation of serum percent trisialotransferrin as potential predictive biomarker of hepatocellular dedifferentiation in chronic liver disease 显示文摘	Gressner OA Jafari S Erkens M	2009	Clin Chim Acta2009，403，12：	1
16	High CSa levels are associated with increased mortality in sepsis patientsno enhancing effect by actin-free Ge-globulin显示文摘	Gressner OA Koch A Sanson E	2008	Clin Biochem2008，41，12：	1
17	Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases显示文摘	Gressner OA Gressner AM	2008	Liver Int2008，28，8：	1
18	Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases 显示文摘	Gressner OA Gressner AM	2008	Liver Int2008，28，8：	1
19	Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options显示文摘	Gressner OA Weiskirchen R Gressner AM	2007	Comp Hepatol2007，6，：	1
20	Biomarkers of hepat- ic fibrosis, fibmgenesis and genetic pre-dispasition pending between fic- tion and reality显示文摘	Gressner OA Weiskirchen R Gressner AM	2007	J Cell Mol Med2007，11，5：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示